SIG +1.92%: Sigma is a chemist retailer operating under brands like Amcal and they also have a large wholesale business, although smaller than it once was after losing the contract to supply Chemist Warehouse a few years ago. They released FY22 results today and presented to us this afternoon. We haven’t really looked at SIG before and find it hard to get excited about the stock right now, although it is in turnaround mode. Today’s result was in line with both guidance and market expectations, FY22 underlying EBITDA of $92.1m was +10.8% on last year and compared to guidance of +10-15%. No FY23 guidance, but expects to return to profit in the period.
scroll
Question asked
Question asked
Performance update for March, stocks that drove returns & our current positioning
Close
Friday 26th April – ASX200 -101pts, Newmont (NEM), Resmed (RMD) & Super Retail (SUL)
Close
Market Matters Research Lead Shawn Hickman with David Koch
Close
MM has no real interest in SIG
Add To Hit List
Related Q&A
Sigma and Chemist Warehouse merger
What are MM’s thoughts on Sigma (SIG)?
Relevant suggested news and content from the site
Video
WATCH
Performance update for March, stocks that drove returns & our current positioning
Recorded Tuesday 9th April
Podcast
LISTEN
Friday 26th April – ASX200 -101pts, Newmont (NEM), Resmed (RMD) & Super Retail (SUL)
Daily Podcast Direct from the Desk
Video
WATCH
Market Matters Research Lead Shawn Hickman with David Koch
Recorded Monday 25th March
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.